Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FS2NH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,022
Award facts
- Contract value 100% obligated
- $81,021.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $81,021.64 delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pens (2 ML) on October 28, 2025, with completion scheduled for October 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's place of performance for this order is its Corporate Office location in Conshohocken, PA.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) SPE2DX with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The IDC enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications and brand-name drugs across multiple therapeutic domains. DUPIXENT (dupilumab) is a biologic medication used to treat moderate-to-severe eczema and other inflammatory conditions, representing the type of specialty pharmaceutical product within AmerisourceBergen's federal contract portfolio that supports Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FS2NH?
SPE2DB26FS2NH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FS2NH worth?
The government has obligated $81,022 on SPE2DB26FS2NH.
Is contract SPE2DB26FS2NH an order under another contract?
Yes. SPE2DB26FS2NH is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB26FS2NH competed?
The extent of competition for SPE2DB26FS2NH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award